v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Current assets:    
Cash, cash equivalents and restricted cash $ 4,169 $ 3,705
Accounts receivable, net of allowance for credit losses of $57 and $83 as of July 31, 2026 and October 31, 2025 7,168 5,692
Inventory 10,322 8,512
Other current assets 5,087 4,544
Total current assets 26,746 22,453
Property, plant and equipment, net 3,110 3,049
Goodwill 8,726 8,706
Other non-current assets 7,119 7,561
Total assets 45,701 41,769
Current liabilities:    
Notes payable and short-term borrowings 1,292 845
Accounts payable 21,383 18,051
Other current liabilities 11,288 10,362
Total current liabilities 33,963 29,258
Long-term debt 7,868 8,821
Other non-current liabilities 3,962 4,036
Stockholders’ deficit:    
Preferred stock, $0.01 par value (300 shares authorized; none issued) 0 0
Common stock, $0.01 par value (9,600 shares authorized; 903 and 921 shares issued and outstanding as of July 31, 2026 and October 31, 2025) 9 9
Additional paid-in capital 2,364 2,129
Accumulated deficit (2,117) (2,027)
Accumulated other comprehensive loss (348) (457)
Total stockholders’ deficit (92) (346)
Total liabilities and stockholders’ deficit $ 45,701 $ 41,769